Introduction of Cancer Molecular Epidemiology Zuo-Feng Zhang, MD, PhD University of California Los Angeles.

Slides:



Advertisements
Similar presentations
Cancer and Cell Biology. Cancer Facts Group of 100 diseases that develop across time Characterized by uncontrolled cell division Can develop in virtually.
Advertisements

What is Epidemiology? (1)
Safety and Extrapolation Steven Hirschfeld, MD PhD Office of Cellular, Tissue and Gene Therapy Center for Biologics Evaluation and Research FDA.
Yan Guo Assistant Professor Department of Cancer Biology Vanderbilt University USA.
William H. Farland, Ph.D. Acting Deputy Assistant Administrator for Science Office of Research and Development U.S. ENVIRONMENTAL PROTECTION AGENCY Biomarkers:
 A public health science (foundation of public health)  Impacts personal decisions about our lifestyles  Affects government, public health agency and.
Environmental Health III. Epidemiology Shu-Chi Chang, Ph.D., P.E., P.A. Assistant Professor 1 and Division Chief 2 1 Department of Environmental Engineering.
Hss4303b – Intro to Epidemiology March 18, 2010 – Molecular & Genetic Epidemiology.
What Do Toxicologists Do?
3 rd Summer School in Computational Biology September 10, 2014 Frank Emmert-Streib & Salissou Moutari Computational Biology and Machine Learning Laboratory.
 Primary liver cancer is the fifth most common cancer in the world and the third most common cause of cancer mortality  Hepatocellular carcinomas (HCCs)
Introduction to Molecular Epidemiology Jan Dorman, PhD University of Pittsburgh School of Nursing
Biomedical research methods. What are biomedical research methods? An integrated approach using chemical, mathematical and computer simulations, in vitro.
Study Designs Manish Chaudhary BPH( IOM),MPH( BPKIHS)
Paola CASTAGNOLI Maria FOTI Microarrays. Applicazioni nella genomica funzionale e nel genotyping DIPARTIMENTO DI BIOTECNOLOGIE E BIOSCIENZE.
Luděk Bláha, PřF MU, RECETOX BIOMARKERS AND TOXICITY MECHANISMS 13 – BIOMARKERS Summary and final notes.
The Nature of Disease.
Supercourse Environmental Exposure Assessment And Biomarkers Wael Al-Delaimy, MD, PhD.
BIOLOGIC MARKERS IN OCCUPATIONAL AND ENVIRONMENTAL MEDICINE By: Dr Chavoshi.
Zuo-Feng Zhang, MD, PhD Epi242, Prospective:  Cohort Studies: Observational studies  Intervention Studies, Clinical Trials  Nested Case-Control.
Tumor Biomarkers are high lightened Once Again Cancer Facts Cancer etiology Tumor Genetics Tumor MarkersLocation Classification Uses methods of detection.
Epidemiology The Basics Only… Adapted with permission from a class presentation developed by Dr. Charles Lynch – University of Iowa, Iowa City.
A brief introduction to Research Methodology By Dr.Shaikh Shaffi Ahamed Ph.d., Asst. Professor Dept. of Family & Community Medicine.
Web of Causation; Exposure and Disease Outcomes Thomas Songer, PhD Basic Epidemiology South Asian Cardiovascular Research Methodology Workshop.
Study Designs Afshin Ostovar Bushehr University of Medical Sciences Bushehr, /4/20151.
Epidemiology. Classically speaking Epi = upon (among) Demos = people Ology = science Epidemiology = the science which deals with what falls upon people…..
 Cancer is a group of more than 100 diseases that develop over time › Involve the uncontrolled division of the body’s cells  Cancer is the 2 nd leading.
LESSON 9.5: TYPES OF STUDIES Module 9: Epidemiology Obj. 9.5: Compare & contrast different types of epidemiological studies.
©Edited by Mingrui Zhang, CS Department, Winona State University, 2008 Identifying Lung Cancer Risks.
Introduction to Pathology And its rule in the diagnostic process Dr: Wael H.Mansy, MD Assistant Professor College of Pharmacy King Saud University.
SEER Provided Data Mohammad Afnan Baqai 12/3/2009.
Biomedical Research. What is Biomedical Research Biomedical research is the area of science devoted to the study of the processes of life; prevention.
Agent-based methods for translational cancer multilevel modelling Sylvia Nagl PhD Cancer Systems Science & Biomedical Informatics UCL Cancer Institute.
Biomarkers Biomarkers - markers in biological systems with a sufficently long half-life which allow location where in the biological system change occur.
Nies and Nies and McEwen: Chapter 4: ATI: Chapter 3 Epidemiology.
Introduction of Pathology
Dr Godfrey Grech University of Malta
Computational Approaches for Biomarker Discovery SubbaLakshmiswetha Patchamatla.
1.
Introduction Hereditary predisposition (mutations in BRCA1 and BRCA2 genes) contribute to familial breast cancers. Eighty percent of the.
Research and Methodology
Michael H. Dong MPH, DrPA, PhD  readings Epidemiology and Risk Assessment (4th of 10 Lectures on Toxicologic Epidemiology)
Organization of statistical research. The role of Biostatisticians Biostatisticians play essential roles in designing studies, analyzing data and.
Part 1d: Exposure Assessment and Modeling Thomas Robins, MD, MPH.
Biologic Monitoring A. H. Mehrparvar, MD Occupational Medicine department Yazd University of Medical Sciences.
Introduction to Pathology And its rule in the diagnostic process Dr: Wael H.Mansy, MD Assistant Professor College of Pharmacy King Saud University.
Cancers of the Digestive System November 19, 2007 NCDD Meeting Chair: John M. Carethers, MD Vice Chair: Robert Sandler, MD, MPH.
BIOSTATISTICS Lecture 2. The role of Biostatisticians Biostatisticians play essential roles in designing studies, analyzing data and creating methods.
Epidemiology. Classically speaking Classically speaking EPI DEMO LOGOS Upon,on,befall People,population,man the Study of The study of anything that happens.
Inflammatory Bowel Diseases November 19, 2007 NCDD Meeting Chair: Daniel K. Podolsky, MD Vice Chair: Eugene B. Chang, MD.
G. M. Jacquez. Our Dear Friend and Colleague Jawaid Rasul 8/2/ /22/2011.
Introduction to General Epidemiology (2) By: Dr. Khalid El Tohami.
Cell Biology & Cancer Unit Objective 1 Cancer types, incidence, pre-disposition, and risk factors Biomedical Technology.
Introduction to Pathology And its rule in the diagnostic process Dr. Atif Ali Bashir, MD Pathology Assistant Professor College of Medicine Majma’ah University.
By: Dr Khalid El Tohami INTRODUCTION TO PUBLIC HEALTH AND EPIDEMIOLOGY (1)
Understanding Epidemiology Introduction to Epidemiology and Epidemiological Concepts.
Cancer and Cell Biology
Cancer prevention and early detection
How Can You Study Human Heredity?
Biologic Monitoring A. H. Mehrparvar, MD
Biomedical Technology
Cell Biology and Cancer Unit H.
Biomedical Research.
Lixia Yao, James A. Evans, Andrey Rzhetsky  Trends in Biotechnology 
Summary of the Standards of Learning
Complete Station Race Assignment…
Using Mode of Action to Reduce Uncertainty in Risk Estimates
Biomedical Technology
The 7th EAHSC Detection of human papillomavirus DNA in tumors from Rwandese breast cancer patients Dr. Habyarimana T1,2,3, Attaleb M1, Mazarati JB3, Bakri.
Epidemiological Designs
Presentation transcript:

Introduction of Cancer Molecular Epidemiology Zuo-Feng Zhang, MD, PhD University of California Los Angeles

Numbers of Papers with Subject Words “Molecular Epidemiology” on Medline

Definition of Epidemiology Epidemiology: Describe distribution patterns of the disease among population, time trend, and places Identify determinants (risk factors/etiological factors) of the disease Disease prevention and control: conduct intervention studies to reduce incidence and mortality of the disease

Epidemiology and Molecular Sciences Epidemiology Molecular Sciences Health effects in grouped people Observation and inference of association between variables Macro Assessment of the individual at the component level Experimental proof of cause and effects Micro

Evolution of General Epidemiology Advances in molecular biology, genetics, analytical chemistry, and other basic sciences have made it possible to measure contaminants, carcinogens, biological changes at a much smaller level. These advances can assist us to assay genetic susceptibility by genotyping and other genetic methods and to identify mechanisms at cellular and molecular levels

Molecular Epidemiology The goal of molecular epidemiology is to supplement and integrate, not to replace, existing methods Molecular epidemiology can be utilized to enhance capacity of epidemiology to understand disease in terms of the interaction of the environment and heredity.

Traditional and Molecular Epidemiology Traditional Molecular Association High exposure and single outcome Prevention through control of exposure is feasible without understanding cellular process Mechanisms Smaller and mixed exposures; multicausal Intervention through cellular process has the need to understand mechanisms of the process

Molecular Epidemiology studies utilizing biological markers of exposure, disease and susceptibility studies which apply current and future generations of biomarkers in epidemiologic research.

Basics of Molecular Epidemiology The term of molecular epidemiology indicates the incorporation of molecular, cellular, and other biological measurements into epidemiologic studies

Biological Markers: Definition of Biological Markers Biological markers can be currently defined as a biological product related to any sequence of multistage carcinogenesis, including tumor initiation and promotion.

Biological Markers Measurement of Biomarkers Biomarkers can be measured quantitatively or qualitatively by biochemical, immunochemical, cytogentic, molecular and genetic techniques.

Biological Markers: Materials for Biomarker Measurement Biomarkers can be measured in human biological materials including normal and tumor tissues, blood and urine sample, etc.. Their biological nature can be DNA, RNA, and protein, etc.

Biological Markers: The Application of Biomarkers Biomarkers can be employed to predict primary or secondary cancer risk, to establish cancer burden, to further classify the tumor in addition to pathological classification, to predict tumor prognosis, to determine treatment strategy, and to evaluate chemo-prevention or intervention.

Capacities of Molecular Epidemiology Identification of Exposure at the smaller scale Identification of events earlier in the nature history of disease Assay susceptibility markers and evaluation of gene-environment interaction In addition, it can be used to reduce misclassification, to indicate mechanisms, and enhance risk assessment

Molecular Epidemiology These capacities provide additional tool for epidemiologists studying questions on etiology, prevention and control of diseases Although molecular epidemiology can be viewed as an evolution step of epidemiology, it generally dose not represent a shift in the basic paradigm of epidemiology

Study of Black Box The concept of a continuum of events between exposure and disease provide opportunities To ensure that epidemiologic research has a biological basis for hypothesis To provide the analysis to test these ideas To generate new epidemiological methods to deal with new challenges

Application: Risk Assessment Molecular epidemiology focuses on identifying high risk individuals and make personalized risk assessments by measuring changes at molecular level, particularly those entailing structure gene damage, gene variation, or the measurement of gene products in cells and body fluids

Application: Genetic Predisposition or Susceptibility Molecular epidemiology utilizes a series of biological markers (exposure, susceptibility, early biological response markers), which include genetic predisposition and susceptibility markers which are usually the major focus of the genetic epidemiology.

The application of Biomarkers Biomarkers can be employed in primary preventive or etiological research by detecting the relationship between environmental exposure and specific mutations. These can be utilized in secondary preventive studies or early detection and diagnosis by identifying markers for tumors at early stage or precursor of tumor. Finally, these markers can be used in tertiary preventive studies or prediction of prognosis by correlating biomarkers with tumor progression and patient survival.

Tasks for Molecular Epidemiologist The major tasks are to reduce misclassification of exposure, to assess effect of exposure on the target tissue, to measure susceptibility/inherited predisposition to cancer, to establish the link between environmental exposures and gene mutations, to assess gene-environment interaction. To set up prevention/intervention strategies.